Publication | Open Access

IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer

Igfbp-3 Methylation-derived DeficiencyIgfir/akt PathwayMedicineBronchial NeoplasmCancer GeneticsRadiation OncologyCancer BiologyCell BiologyEpigeneticsLung CancerTumor Biology